The effects and mechanism of saponins of panax notoginseng on glucose metabolism in 3T3-L1 cells

American Journal of Chinese Medicine

Volumn 37, Issue 6, 2009, Pages 1179-1189

  Kim, Jane J Y ^a   Xiao, Hong ^a   Tan, Yi ^a   Wang, Zheng Zhong ^b   Paul Seale, J ^c   Qu, Xianqin ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b Kanion Pharmaceuticals   (China)

^c University of Sydney   (Australia)

Author keywords

3T3 L1 Adipocytes; Glucose Uptake; GLUT4 Translocation; Glycogen Synthesis; Saponins of Panax notoginseng

Indexed keywords

DEOXYGLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; SAPONIN DERIVATIVE; TRITIUM;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL MEMBRANE; CELL STRAIN 3T3; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG POTENTIATION; DRUG SCREENING; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PANAX NOTOGINSENG;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; BIOLOGICAL TRANSPORT; CELL MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; GLYCOGEN; HYPOGLYCEMIC AGENTS; INSULIN; MICE; PANAX NOTOGINSENG; PLANT EXTRACTS; SAPONINS;

EID: 76449087141     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X09007582     Document Type: Article

References (19)

1. Dey, L., J.T.Xie,A.Wang, J.Wu, S.A.Maleckar andC.S.Yuan.Anti- hyperglycemic effects of ginseng: comparison between root and berry. Phytomedicine 10: 600-605, 2003.
2. Dong, T.T.X., X.M. Cui, Z.H. Song, K.J. Zhao, N.J. Zhao, C.K. Lo and W.K. Tsim. Chemical assessment of roots of Panax notoginseng in China: regional and seasonal variations in its active constituents. J. Agric. Food Chem. 51: 4617, 2003.
3. Hess, S.L., C.R. Suchin and A.R. Saltiel, The specific protein phosphatise inhibitor okadaic acid differentially modulates insulin action. J. Cell. Biochem. 45: 374-380, 1991.
4. Hu,G., P. Jousilahti and G. Tuomilehto. 10-year trends in prevalence of themetabolic syndrome among Finnish adults. Diabetologia 49: 233, 2007.
5. Liu, K.Z., J.B. Li, H.L. Lu, J.K. Wen and M. Han. Effects of Astragalus and saponins of Panax notoginseng on MMP-9 in patients with type 2 diabetic macroangiopathy. Zhongguo Zhong Yao Za Zhi 29: 264-266, 2004.
6. Moller, D.E. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414: 821-827, 2001.
7. Morino, K., K.F. Petersen and G.I. Shulman. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 55: S9-S15, 2006.
8. Ng, T.B. Pharmacological activity of sanchi ginseng (Panax notoginseng). J. Pharm. Pharmacol. 58: 1007-1019, 2006.
9. National Institute of Diabetes and Digestive and Kidney Diseases. National Diabetes Statistics, 2007
10. Fact Sheet. Department of Health and Human Services, National Institutes of Health, Bethesda, MD US, 2008.
11. Norris, S.L., S. Carson and C. Roberts. Comparative effectiveness of pioglitazone and rosiglitazone in type 2 diabetes, prediabetes, and the metabolic syndrome: a meta-analysis. Curr. Diabetes Rev. 3: 127-140, 2007.
12. Shaw, J. and D. Chisholm. Epidemiology and prevention of type 2 diabetes and the metabolic syndrome. MJA 179: 379-383, 2003.
13. Ursø, B., D.L. Cope, H.E. Kalloo-Hosein, et al. Differences in signaling properties of the cytoplasmic domains of the insulin receptor and insulin-like growth factor receptor in 3T3-L1 adipocytes. J. Biol. Chem. 274: 30864-30873, 1999.
14. Wang, C.Z. and C.S. Yuan. Potential role of ginseng in the treatment of colorectal cancer. Am. J. Chin. Med. 36: 1019-1028, 2008.
15. Wang, C.Z., M. Ni, S. Sun, X.L. Li, H. He, S.R. Mehendale and C.S. Yuan. Detection of adulteration of notoginseng root extract with other panax species by quantitative HPLC coupled with PCA. J. Agric. Food Chem. 57: 2363-2367, 2009.
16. Yao, X.H. and X.J. Li. Protective effects and its mechanism of panaxatriol saponins isolated from Panax notoginseng on cerebral ischemia. Zhongguo Zhong Yao Za Zhi 27: 371-373, 2002.
17. Zhang,H.S. andQ.Wang.NotoginsenosideR1 fromPanax notoginseng inhibits TNF-?-induced PAI-1 production in human aortic smooth muscle cells. Vascul. Pharmacol. 44: 224-230, 2006.
18. Zhou, L., X.Wang, S. Liu, et al. Berberine stimulates glucose transport through a mechanism distinct from insulin. Metab. Clin. Exp. 56: 405-412, 2007.
19. Zimmet, K. and J. Shaw. Global and societal implications of the diabetes epidemic. Nat. Med. 414: 782-787, 2001.